苑东生物
(688513)
| 流通市值:68.61亿 | | | 总市值:68.61亿 |
| 流通股本:1.76亿 | | | 总股本:1.76亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 990,447,319.93 | 658,897,905.28 | 326,262,896.49 | 1,331,390,248.33 |
| 营业总成本 | 837,852,803.92 | 569,884,268.06 | 295,762,658.95 | 1,122,067,149.82 |
| 其他经营收益 | | | | |
| 营业利润 | 206,115,200.53 | 132,808,499.73 | 47,361,946.72 | 314,630,247.51 |
| 利润总额 | 206,936,328.36 | 134,240,093.13 | 47,401,262.93 | 299,651,029.1 |
| 净利润 | 177,016,942.02 | 112,103,602.37 | 43,281,766.32 | 273,573,868.43 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 177,016,942.02 | 112,103,602.37 | 43,281,766.32 | 273,573,868.43 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,262,426,510.62 | 2,162,045,387.77 | 2,117,374,283.67 | 2,132,164,292.56 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,676,505,728.15 | 1,662,133,480.35 | 1,660,070,269.89 | 1,665,715,014.65 |
| 资产总计 | 3,938,932,238.77 | 3,824,178,868.12 | 3,777,444,553.56 | 3,797,879,307.21 |
| 流动负债: | | | | |
| 流动负债合计 | 737,479,074.2 | 665,666,021.73 | 553,638,224.97 | 618,696,725.44 |
| 非流动负债: | | | | |
| 非流动负债合计 | 136,787,087 | 136,752,723.83 | 137,849,145.31 | 140,207,073.79 |
| 负债合计 | 874,266,161.2 | 802,418,745.56 | 691,487,370.28 | 758,903,799.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,989,434,104.43 | 2,933,271,121.34 | 2,987,369,133.16 | 2,932,838,202.3 |
| 股东权益合计 | 3,064,666,077.57 | 3,021,760,122.56 | 3,085,957,183.28 | 3,038,975,507.98 |
| 负债和股东权益合计 | 3,938,932,238.77 | 3,824,178,868.12 | 3,777,444,553.56 | 3,797,879,307.21 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,137,620,117.07 | 803,415,094.68 | 410,262,365.73 | 1,513,255,802.36 |
| 经营活动现金流出小计 | 923,425,605.11 | 636,018,833.62 | 314,706,795.06 | 1,248,314,598.14 |
| 经营活动产生的现金流量净额 | 214,194,511.96 | 167,396,261.06 | 95,555,570.67 | 264,941,204.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,230,150,924.83 | 738,593,251.48 | 425,123,849.69 | 1,331,819,177.43 |
| 投资活动现金流出小计 | 1,860,403,688.68 | 1,357,847,407.46 | 978,742,257.77 | 1,698,271,036.18 |
| 投资活动产生的现金流量净额 | -630,252,763.85 | -619,254,155.98 | -553,618,408.08 | -366,451,858.75 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 209,120,216.95 | 124,506,959.23 | 8,289,443.67 | 205,510,482.41 |
| 筹资活动现金流出小计 | 273,948,075.38 | 229,113,908.02 | 74,559,786.21 | 231,829,982.87 |
| 筹资活动产生的现金流量净额 | -64,827,858.43 | -104,606,948.79 | -66,270,342.54 | -26,319,500.46 |
| 汇率变动对现金及现金等价物的影响 | -1,494,647.57 | -1,063,542.42 | -423,703.76 | -470,178.96 |
| 现金及现金等价物净增加额 | -482,380,757.89 | -557,528,386.13 | -524,756,883.71 | -128,300,333.95 |
| 期末现金及现金等价物余额 | 354,497,413.35 | 279,349,785.11 | 312,121,287.53 | 836,878,171.24 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -557,528,386.13 | - | -128,300,333.95 |
最新报告期:2026-09-17| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西部证券 | 李梦园 | 1.68 | 1.88 | 2.12 | 2026-09-17 |
| 华源证券 | 刘闯 | 1.59 | 1.77 | 2.05 | 2026-09-13 |
| 浙商证券 | 盖文化,郭双喜 | 1.62 | 1.78 | 2.03 | 2026-08-26 |
| 东吴证券 | 朱国广 | 1.64 | 1.81 | 2.01 | 2026-08-24 |
| 中信建投 | 沈毅,袁清慧 | 1.47 | 1.68 | 1.97 | 2026-08-22 |